Table 5.

% fenofibrate in aqueous phase (AP) and pellet phase (PP) after 30 min digestion under fed and fasted condition, (n = 3 ± SD).

No.	Formulation	Fasted			Fed
		% Drug in AP	% Drug in PP	%Tot. Rec.	% Drug in AP	% Drug in PP	%Tot. Rec.
F2a	C70:CMCM(7:3)/TO106V (1/1)	9.22 ± 0.67	79.23 ± 1.23	88.45	8.99 ± 1.11	78.99 ± 0.77	87.98
F2b	K70:I742(7:3)/To-106V(1/1)	11.23 ± 3.23	84.79 ± 0.87	96.02	10.09 ± 0.21	83.36 ± 1.07	93.45
F3a	C70:CMCM(7:3)/ HCO-30 (1/1)	08.24 ± 0.00	78.72 ± 0.20	86.96	07.20 ± 0.61	85.44 ± 0.02	92.64
F3b	K70:I742(7:3)/HCO-30 (1/1)	10.18 ± 0.00	83.41 ± 0.80	93.59	4.84 ± 0.00	88.68 ± 1.11	93.52
F4a	CMCM/HCO-30 (1/1)	7.64 ± 2.11	84.81 ± 0.44	92.45	7.43 ± 1.32	84.23 ± 3.11	91.66
F4b	I742/ HCO-30 (1/1)	9.79 ± 0.03	86.75 ± 0.00	96.54	8.75 ± 0.50	85.29 ± 0.93	92.04

Concentration of fenofibrate (mg) in mixed BS micelles before and after digestion under fed conditions. The data represent the original mass of fenofibrate which was recovered from the aqueous and pellet phases after digestion.